CLARKE JOHN K - Insider Non-Derivative Transactions at aTYR PHARMA INC (LIFE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Apr 26, 2023, CLARKE JOHN K's relationship to aTYR PHARMA INC (LIFE) is Director, and currently has 19,797 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LIFE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

CLARKE JOHN K - Insider Non-Derivative Transactions of LIFE Common Stock

CLARKE JOHN K - Insider Non-Derivative Transactions at LIFE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Apr 27, 2023	M -- (Common Stock)	6000	0	19797